@Wishful All the researchers think there are subgroups, even McGregor:
...he’s able to separate infectious from gradual onset patients using metabolites. To be able to show, years after onset, that some fundamental differences persist in these two groups would be a significant breakthrough. Not only would it suggest that gradual and infectious onset patients are different, but the metabolites should, of course, tell us how these two symptomatically very similar presentations of ME/CFS are different biologically....
There definitely seem to be more subgroups, but I'd venture to say there are actuslly an infinite number of subgroups and what we really need is personalized medicine.
I say this not to be difficult, but because, even if these major subgroups did have the limited research dollars applied, it wouldn't be useful to me, because my subgroup is unique - there are no other patients like me.
I have post-hysterectomy/chemotherapy for ovarian/uterine cancer, significant car accident affecting my spine, Epstein Barr and other viral induced immunity, heriditary hemochromatosis, Hashimotos, Celiac, MCAS, lousy genes onset ME/CFS.
The best a patient like me can do is not sit around waitung for the researchers to get around to RCTs of treatments on patients exactly like me, cause it just ain't gonna happen. It's reading the research out there, comparing my diagnostics to what's found By the researchers and to take actions to push me toward normal.
So, I appreciate experienced researchers like McGregor theorizing as it helps inform my doctors' and my decision-making process in developing treatment.
As for McGregor's theory, it is much more than just glucose. Aminos seem to be a key, as others have found many of us are burning aminos for fuel, taken grom our muscles. This jives with Fluge and Mella's findings on amino acid depletion. (And my labs have agreed - unless I get my amino acid intake up to 1.8-2g/kg/day, I get depleted which has led to numerous problems that reverse with adequate supplementation.)
Our cells want to use glucose to produce energy; if they can’t get glucose they’ll turn to fats – not such a bad substitute, but if the fats aren’t working, they’re forced to turn to their last and least favorite option – breaking down proteins....
...High levels of muscle metabolites suggested that whatever muscles the people with ME/CFS had left were being broken down faster than normal....
...This dumping/amino acid depletion is, McGregor believes, a key issue in ME/CFS. It can help explain why ATP production is low and why the disease is so darn difficult to get out of...
But then he discussed HDAC problems in concert with low pyruvate and low lactate, again something that my labs have shown.
Bringing us back to square one, he proposed that the HDAC problems in ME/CFS result from the problems with glycolysis.
Glycolytic inhibition, it turns out, increases HDAC activity. Low lactate and pyruvate levels – because they are HDAC inhibitors – allow HDAC levels to rise. HDAC then causes deacetylation and silences the transcription of many genes.
2 years ago, my fasting glucose was high even though I was on a low carb diet. But, as I've treated infections, learned about the amino acid problems and replenished them, I've improved. I remain on a low carb, high protein diet, so perhaps I'm not seeing the insulin resistance and glycolysis problems McGregor sees due to the interventions I've made.
It would be interesting to learn more about the dynamics of all of this, what tests could be used by clinicians, what treatments might effective, and how one would measure progress.